Samsung Biologics, Top Search Ranking... Stock Price Up 6.82%
Samsung Biologics has ranked among the top searched stocks for 3 days in the past month.
As of 2:31 PM on the 5th, Samsung Biologics is trading at 783,000 KRW, up 6.82% from the previous day. This marks a 24.29% increase compared to October 26. Samsung Biologics is known as the holding company for Samsung Group's bio business.
Today, foreigners have net purchased 50,721 shares of Samsung Biologics, and institutions have net purchased 23,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 212,638 shares, while foreigners and institutions have net bought 33,437 shares and 175,511 shares, respectively.
On November 4, Samsung Biologics was a market highlight for its "strong performance on a 18.3 billion KRW pharmaceutical contract manufacturing agreement."
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
